Resultats globals: 12 registres trobats en 0.02 segons.
Articles, 12 registres trobats
Articles 12 registres trobats  1 - 10següent  anar al registre:
1.
22 p, 279.7 KB Identificación de las carencias asistenciales en la atención clínica del asma en España : resultados de la encuesta OPTIMA-GEMA / Plaza, Vicente (Institut d'Investigació Biomèdica Sant Pau) ; Rodriguez del Rio, Pablo (Hospital Niño Jesús (Madrid)) ; Gómez Ruiz, Fernando (Centro de Salud de Bargas (Toledo)) ; López Viña, Antolín (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Molina París, Jesús (EAP Francia I (Fuenlabrada, Madrid)) ; Quintano Jiménez, José Antonio (Centro de Salud Lucena (Córdoba)) ; Quirce Gancedo, Santiago (Fundación para la Investigación Biomédica del Hospital Universitario La Paz) ; Soler Vilarrasa, Ramona (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Villa Asensi, José Ramón (Hospital Infantil Universitario Niño Jesús (Madrid)) ; Nieto Garcíá, Antonio (Hospital Universitari i Politècnic La Fe (València))
Fundamento. En línea con el lanzamiento de la guía GEMA2009, el objetivo del estudio fue identificar y evaluar las carencias en la implementación de las recomendaciones de la misma y proponer iniciativas de mejora. [...]
Background: Based on the GEMA 2009 guidelines (Spanish Asthma Management Guidelines), this project identified and assessed the main deficiencies in the implementation of the guidelines and proposed initiatives for improvement. [...]

2016 - 10.23938/ASSN.0274
Anales del sistema sanitario de Navarra, Vol. 39 Núm. 2 (2016) , p. 181-201  
2.
28 p, 1.5 MB Quality assessment of peripheral artery disease clinical guidelines / Barriocanal, Ana Maria (Institut Germans Trias i Pujol) ; López, Anna (Institut Germans Trias i Pujol) ; Monreal, Manuel (Universitat Autònoma de Barcelona. Departament de Medicina) ; Montané, Eva (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Background Clinical practice guidelines (CPGs) provide recommendations to assist health professionals and patients in the process of making decisions for specific clinical conditions to improve the quality of the patient care. [...]
2016 - 10.1016/j.jvs.2015.12.040
Journal of Vascular Surgery, Vol. 63 Núm. 4 (january 2016) , p. 1091-1098  
3.
5 p, 347.5 KB SEOM clinical guideline in nasopharynx cancer (2017) / Pastor, M. (Hospital La Fe de València) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; del Barco, E. (Complejo Asistencial Universitario de Salamanca) ; Perez Segura, P. (Hospital Clínico San Carlos (Madrid)) ; Astorga, B.G. (Hospital Universitario San Cecilio (Granada)) ; Castelo, B. (Hospital Universitario La Paz (Madrid)) ; Bonfill Abella, Teresa (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Martinez Trufero, J. (Hospital Universitario Miguel Servet (Saragossa)) ; Grau, Juan Jose (Hospital Clínic i Provincial de Barcelona) ; Mesía, Ricard (Institut Català d'Oncologia) ; Universitat Autònoma de Barcelona
Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiation therapy is an essential component of curative-intent of non-disseminated disease and the association of chemotherapy improves the rates of survival. [...]
2018 - 10.1007/s12094-017-1777-0
Clinical & Translational Oncology, Vol. 20 Núm. 1 (january 2018) , p. 84-88  
4.
28 p, 397.3 KB EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study) / Lam, T.B.L. (Aberdeen Royal Infirmary) ; MacLennan, S. (University of Aberdeen) ; Willemse, P.P.M. (University Medical Center Utrecht) ; Mason, M.D. (Velindre Cancer Centre) ; Plass, K. (EAU Guidelines Office) ; Shepherd, R. (EAU Guidelines Office) ; Baanders, R. ; Bangma, C.H. (Erasmus University Medical Centre) ; Bjartell, Anders (Lund University) ; Bossi, A. (Gustave Roussy Institute) ; Briers, E. ; Briganti, A. (Scientific Institute and University Vita-Salute San Raffaele Hospital) ; Buddingh, K.T. (HagaZiekenhuis) ; Catto, J.W.F. (Royal Hallamshire Hospital) ; Colecchia, M. (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano) ; Cox, B.W. (Zucker School of Medicine) ; Cumberbatch, M.G. (University of Sheffield) ; Davies, J. ; Davis, N.F. (Royal College of Surgeons in Ireland) ; De Santis, M. (Charité University Hospital) ; Dell'Oglio, P. (ORSI Academy) ; Deschamps, A. (Europa Uomo) ; Donaldson, J.F. (Aberdeen Royal Infirmary) ; Egawa, S. (Jikei University School of Medicine) ; Fankhauser, C.D. (University of Zurich) ; Fanti, S. (University of Bologna) ; Fossati, N. (Scientific Institute and University Vita-Salute San Raffaele Hospital) ; Gandaglia, G. (IRCCS Ospedale San Raffaele) ; Gillessen, S. (University of Bern) ; Grivas, N. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; Gross, T. (University of Bern) ; Grummet, J.P. (Monash University) ; Henry, A.M. (St. James's University Hospital) ; Ingels, A. (Henri Mondor Hospital) ; Irani, J. (University Hospital of Bicêtre-Paris Sud-Saclay University) ; Lardas, M. (Department of Reconstructive Urology and Surgical Andrology) ; Liew, M. (Wigan and Leigh NHS Foundation Trust) ; Lin, D.W. (University of Washington) ; Moris, L. (KU Leuven) ; Omar, M.I. (University of Aberdeen) ; Pang, K.H. (University of Sheffield) ; Paterson, C.C. (Robert Gordon University) ; Renard-Penna, R. (Sorbonne Université) ; Ribal, María J. (Hospital Clínic i Provincial de Barcelona) ; Roobol, M.J. (Erasmus University Medical Centre) ; Rouprêt, M. (Sorbonne Université) ; Rouvière, O. (Université de Lyon) ; Sancho-Pardo, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Richenberg, J. (Royal Sussex County Hospital Brighton and Brighton and Sussex Medical School) ; Schoots, I.G. (Erasmus University Medical Center) ; Sedelaar, J.P.M. (Radboud University Medical Centre) ; Stricker, P. (Garvan Institute of Research) ; Tilki, D. (University Hospital Hamburg-Eppendorf) ; Vahr Lauridsen, S. (Copenhagen University Hospital) ; van den Bergh, R.C.N. (St. Antonius Hospital) ; Van den Broeck, T. (University Hospitals Leuven (Bèlgica)) ; van der Kwast, T.H. (Erasmus University Medical Center) ; van der Poel, H.G. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; van Leenders, G.J.L.H. (Erasmus University Medical Center) ; Varma, M. (University Hospital of Wales) ; Violette, P.D. (McMaster University (Canadà)) ; Wallis, C.J.D. (Vanderbilt University Medical Center) ; Wiegel, T. (University Hospital of Ulm (Alemanya)) ; Wilkinson, K. (University College London Hospitals) ; Zattoni, F. (Academic Medical Centre Hospital) ; N'Dow, J.M.O. (Aberdeen Royal Infirmary) ; Van Poppel, H. (University Hospitals Leuven (Bèlgica)) ; Cornford, P. (Royal Liverpool and Broadgreen Hospitals NHS Trust) ; Mottet, N. (University Hospital Jean Monnet) ; Universitat Autònoma de Barcelona
There is uncertainty in deferred active treatment (DAT) programmes, regarding patient selection, follow-up and monitoring, reclassification, and which outcome measures should be prioritised. To develop consensus statements for all domains of DAT. [...]
2019 - 10.1016/j.eururo.2019.09.020
European Urology, Vol. 76 Núm. 6 (december 2019) , p. 790-813  
5.
12 p, 2.8 MB Radiotherapy Treatment plannINg study Guidelines (RATING) : A framework for setting up and reporting on scientific treatment planning studies / Hansen, C.R. (Aarhus University Hospital (Aarhus, Dinamarca)) ; Crijns, W. (UZ Leuven) ; Hussein, M. (National Physical Laboratory) ; Rossi, Linda (Erasmus MC Cancer Institute) ; Gallego, Pedro (Institut d'Investigació Biomèdica Sant Pau) ; Verbakel, W. (University Medical Center) ; Unkelbach, J. (University Hospital Zurich (Suïssa)) ; Thwaites, D. (University of Sydney) ; Heijmen, B. (Erasmus MC Cancer Institute) ; Universitat Autònoma de Barcelona
Radiotherapy treatment planning studies contribute significantly to advances and improvements in radiation treatment of cancer patients. They are a pivotal step to support and facilitate the introduction of novel techniques into clinical practice, or as a first step before clinical trials can be carried out. [...]
2020 - 10.1016/j.radonc.2020.09.033
Radiotherapy and Oncology, Vol. 153 (december 2020) , p. 67-78  
6.
16 p, 731.1 KB The Changing Asthma Management Landscape and Need for Appropriate SABA Prescription / Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Singh, Dave (Manchester University National Health Service Foundation Trust) ; Universitat Autònoma de Barcelona
Short-acting β agonists (SABAs) have been a mainstay of asthma treatment since the 1950s, and have been mainly recommended as-needed for symptom relief alongside daily inhaled corticosteroid (ICS)-based maintenance treatment for the past 30 years. [...]
2023 - 10.1007/s12325-022-02410-z
Advances in Therapy, Vol. 40 (january 2023) , p. 1301-1316  
7.
7 p, 1.1 MB Survey on the management of Pompe disease in routine clinical practice in Spain / Domínguez-González, C (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Díaz-Marín, Carmina (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Juntas-Morales, Raúl (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Nascimiento-Osorio, Andrés (Hospital Sant Joan de Déu. Unitat Neuromuscular. Servei de Neurologia. Recerca aplicada en malalties neuromusculars. Institut de Recerca Sant Joan de Déu. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER). Instituto de Salud Carlos III) ; Rivera-Gallego, Alberto (Hospital Álvaro Cunqueiro (Vigo)) ; Diaz-Manera, Jordi (Institut d'Investigació Biomèdica Sant Pau)
Background: Despite the availability of several clinical guidelines, not all health professionals use their recommendations to manage patients with Pompe disease, a rare genetic disorder involving high-impact therapy. [...]
2022 - 10.1186/s13023-022-02574-5
Orphanet Journal of Rare Diseases, Vol. 17 Núm. 1 (december 2022) , p. 426  
8.
14 p, 2.6 MB Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts / Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Miah, Aisha B. (The Royal Marsden Hospital) ; Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Messiou, Christina (Department of Radiology. The Royal Marsden Hospital and The Institute of Cancer Research) ; Morosi, Carlo (Radiology Department. Fondazione IRCCS Istituto Nazionale Tumori) ; Caraceni, Augusto (Fondazione IRCCS Istituto Nazionale Tumori) ; Antonescu, Cristina R. (Memorial Sloan Kettering Cancer Center) ; Bajpai, Jyoti (Homi Bhabha National Institute. Medical Oncology Department) ; Baldini, Elizabeth Healey (Dana-Farber Cancer Center/Brigham) ; Bauer, Sebastian (University of Duisburg-Essen) ; Biagini, Roberto (Regina Elena National Cancer Institute) ; Bielack, Stefan S. (Klinikum Stuttgart - Olgahospital) ; Blay, Jean-Yves (Department of Medical Oncology. Centre Leon Berard. Université Claude Bernard Lyon. Unicancer) ; Bonvalot, Sylvie (Institut Curie. Department of Surgical Oncology) ; Boukovinas, Ioannis P. (Nordix) ; Bovee, Judith V.M.G. (Leiden University Medical Center) ; Boye, Kjetil (The Norwegian Radium Hospital) ; Brodowicz, Thomas (Medical University Vienna) ; Callegaro, Dario (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; De Álava, Enrique (Department of Normal and Pathological Cytology and Histology. School of Medicine. University of Seville) ; Deoras-Sutliff, M. (The EHE Foundation) ; Dufresne, Armelle (Department of Medical Oncology. Centre Leon Berard. Université Claude Bernard Lyon. Unicancer) ; Eriksson, Mikael (Department of Oncology. Skane University Hospital and Lund University) ; Errani, Costantino (Orthopaedic Service. Musculoskeletal Oncology Department. IRCCS Istituto Ortopedico Rizzoli) ; Fedenko, Alexander (Medical Oncology Division. P.A. Herzen Cancer Research Institute) ; Ferraresi, Virginia (Sarcomas and Rare Tumors Unit. IRCCS Regina Elena National Cancer Institute) ; Ferrari, Andrea (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Fletcher, Christopher D.M. (Department of Pathology Brigham & Women's Hospital) ; Garcia del Muro, Xavier (Universitat de Barcelona) ; Gelderblom, Hans J. (Department of Medical Oncology. Leiden University Medical Center) ; Gladdy, Rebecca A. (University of Toronto and Lunenfeld-Tanenbaum Research Institute) ; Gouin, François (Department of Surgery. Centre Leon Berard) ; Grignani, Giovanni (Candiolo Cancer Institute. FPO - IRCCS) ; Gutkovich, J. (NUY Langone Medical Center) ; Haas, Rick (Department of Radiotherapy. the Leiden University Medical Center) ; Hindi, Nadia (Universidad de Sevilla. Instituto de Biomedicina de Sevilla) ; Hohenberger, Peter (Mannheim University Medical Center) ; Huang, Paul (Division of Molecular Pathology. The Institute of Cancer Research) ; Joensuu, Heikki T. (Department of Oncology. Helsinki University Hospital & Helsinki University) ; Jones, Robin Lewis (Department of Cancer. The Royal Marsden Hospital and The Institute of Cancer Research) ; Jungels, Christiane (Institut Jules Bordet. Université Libre de Bruxelles) ; Kasper, Bernd (University of Heidelberg. Mannheim University Medical Center. Sarcoma Unit) ; Kawai, Akira (Musculoskeletal Oncology and Rehabilitation Medicine. Rare Cancer Center National Cancer Center Hospital) ; Le Cesne, Axel (International Department. Gustave Roussy) ; Le Grange, Franél (UCLH - University College London Hospitals NHS Foundation Trust) ; Leithner, Andeas (Department of Orthopaedics and Trauma Medical University Graz) ; Leonard, H. (Chair of Trustees of the EHE Rare Cancer Charity (UK). Charity number 1162472) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Martin Broto, Javier (Hospital Universitario Fundación Jiménez Díaz) ; Merimsky, Ofer (Unit of Soft Tissue and Bone Oncology. Division of Oncology. Tel-Aviv Medical Center affiliated with Sackler School of Medicine. Tel Aviv University) ; Merriam, Priscilla (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ; Miceli, Rosalba (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Mir, Olivier (Sarcoma Group. Gustave Roussy) ; Molinari, Massimo (University of Pittsburgh Medical Center. Thomas Starzl Transplant Institute) ; Montemurro, Michael (Oncology. CHUV Lausanne) ; Oldani, Graziano (Division of Abdominal Surgery. University Hospitals of Geneva) ; Palmerini, Emanuela (Chemotherapy Unit. IRCCS Istituto Ortopedico Rizzoli) ; Pantaleo, Maria Abbondanza. (Division of Oncology. IRCCS Azienda Ospedaliero-Universitaria di Bologna) ; Patel, Sapna Pradyuman (Sarcoma Center. The University of Texas M.D. Anderson Cancer Center) ; Piperno-Neumann, Sophie (Department of Medical Oncology. Institut Curie) ; Raut, Chandrajit Premanand (Dana Farber Cancer Center. Harvard Medical School) ; Ravi, Vinod (Sarcoma Center. The University of Texas M.D. Anderson Cancer Center) ; Razak, Albiruni Ryan Abdul (Princess Margaret Cancer Centre and Sinai Healthcare System & Faculty of Medicine. University of Toronto) ; Reichardt, Peter (Helios Klinikum Berlin-Buch. Department of Oncology and Palliative Care) ; Rubin, Brian P. (Robert J. Tomsich Pathology and Laboratory Medicine Institute. Cleveland Clinic) ; Rutkowski, Piotr (Maria Sklodowska-Curie National Research Institute of Oncology. Department of Soft Tissue/Bone Sarcoma and Melanoma) ; Safwat, Akmal Ahmed (Aarhus University Hospital (Aarhus, Dinamarca)) ; Sangalli, Claudia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Sapisochin, Gonzalo (Multi-Organ Transplant and HPB Surgical Oncology. Division of General Surgery. Department of Surgery. University of Toronto) ; Sbaraglia, Marta (Department of Pathology. Azienda Ospedaliera Università Padova) ; Scheipl, Susanne (Department of Orthopaedics and Trauma. Medical University of Graz) ; Schöffski, Patrick (Leuven Cancer Institute) ; Strauss, Dirk Cornelius (Department of Surgery. The Royal Marsden Hospital and The Institute of Cancer Research) ; Strauss, Sandra J. (University College London Hospital) ; Sundby Hall, Kirsten (Department of Oncology. Oslo University Hospital. The Norwegian Radium Hospital) ; Tap, William D. (Department of Medicine. Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College) ; Trama, Annalisa (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Tweddle, A. (Palliative Care. The Royal Marsden Hospital and The Institute of Cancer Research London) ; van der Graaf, Winette T.A. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; van de Sande, Michiel (Department of Orthopedic Surgery Bone and Soft Tissue Tumor Unit. Leiden University Medical Center) ; Van Houdt, Winan (Sarcoma and Melanoma Unit. The Netherlands Cancer Institute) ; van Oortmerssen, Gerard (Co-Chair of Sarcoma Patients EuroNet (SPAEN). Woelfersheim. Germany & Chairman of the Dutch organisation for sarcoma patients (Patiëntenplatform Sarcomen). Guest researcher at Leiden University (Leiden Institute for Advanced Computer Science). Leiden University) ; Wagner, Andrew J. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ; Wartenberg, Markus (Chair of the Board of Directors of Sarcoma Patients EuroNet (SPAEN). Sarcoma Patients EuroNet (SPAEN)) ; Wood, J. (The Royal Marsden NHS Foundation Trust) ; Zaffaroni, Nadia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Zimmermann, Camilla (Department of Supportive Care. Princess Margaret Cancer Centre and Division of Palliative Medicine. Department of Medicine. University of Toronto) ; Casali, Paolo Giovanni (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Dei Tos, Angelo (Department of Pathology. Azienda Ospedaliera Università Padova) ; Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia))
Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is marked by a high propensity for systemic involvement. [...]
2021 - 10.1016/j.esmoop.2021.100170
ESMO open, Vol. 6 Núm. 3 (june 2021) , p. 100170  
9.
10 p, 1.1 MB Mortality risk estimation in acute calculous cholecystitis : beyond the Tokyo Guidelines / González-Castillo, Ana María (Institut Hospital del Mar d'Investigacions Mèdiques) ; Sancho Insenser, Joan Josep (Institut Hospital del Mar d'Investigacions Mèdiques) ; de Miguel-Palacio, Maite (Institut Hospital del Mar d'Investigacions Mèdiques) ; Morera-Casaponsa, Josep-Ricard (Universitat Autònoma de Barcelona) ; Membrilla Fernández, Estela (Institut Hospital del Mar d'Investigacions Mèdiques) ; Pons-Fragero, María-José (Institut Hospital del Mar d'Investigacions Mèdiques) ; Pera, Miguel (Institut Hospital del Mar d'Investigacions Mèdiques) ; Grande, L (Institut Hospital del Mar d'Investigacions Mèdiques) ; Universitat Autònoma de Barcelona
Acute calculous cholecystitis (ACC) is the second most frequent surgical condition in emergency departments. The recommended treatment is the early laparoscopic cholecystectomy; however, the Tokyo Guidelines (TG) advocate for different initial treatments in some subgroups of patients without a strong evidence that all patients will benefit from them. [...]
2021 - 10.1186/s13017-021-00368-x
World Journal of Emergency Surgery : WJES, Vol. 16 (may 2021)  
10.
25 p, 2.1 MB Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas / García-Carbonero, Rocío (Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12)) ; Matute Teresa, F. (Hospital Clínico San Carlos (Madrid)) ; Mercader-Cidoncha, E. (Hospital General Universitario Gregorio Marañón) ; Mitjavila-Casanovas, M. (Grupo de Trabajo de Endocrino de la SEMNIM, Madrid, Spain) ; Robledo, Mercedes (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Tena, I. (Hospital Provincial. Medical Oncology Department) ; Álvarez-Escolá, Cristina (Hospital Universitario La Paz (Madrid)) ; Arístegui, M. (Hospital General Universitario Gregorio Marañón) ; Bella-Cueto, Maria Rosa (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Ferrer-Albiach, C. (Consorci Hospitalari Provincial de Castelló) ; Hanzu, Felicia A (Institut d'Investigacions Biomèdiques August Pi i Sunyer)
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that arise from chromaffin cells of the adrenal medulla and the sympathetic/parasympathetic neural ganglia, respectively. The heterogeneity in its etiology makes PPGL diagnosis and treatment very complex. [...]
2021 - 10.1007/s12094-021-02622-9
Clinical & Translational Oncology, Vol. 23 (may 2021) , p. 1995-2019  

Articles : 12 registres trobats   1 - 10següent  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.